Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Current Assets (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Current Assets for 3 consecutive years, with $114.1 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 71.87% to $114.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $114.1 million through Dec 2025, up 71.87% year-over-year, with the annual reading at $114.1 million for FY2025, 71.87% up from the prior year.
  • Current Assets hit $114.1 million in Q4 2025 for Camp4 Therapeutics, up from $77.7 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $114.1 million in Q4 2025 to a low of $5.5 million in Q3 2024.
  • Historically, Current Assets has averaged $56.6 million across 3 years, with a median of $51.7 million in 2025.
  • Biggest five-year swings in Current Assets: surged 65.9% in 2024 and later soared 1311.85% in 2025.
  • Year by year, Current Assets stood at $40.0 million in 2023, then soared by 65.9% to $66.4 million in 2024, then soared by 71.87% to $114.1 million in 2025.
  • Business Quant data shows Current Assets for CAMP at $114.1 million in Q4 2025, $77.7 million in Q3 2025, and $41.1 million in Q2 2025.